CHMP recommends AbbVie’s Rinvoq be approved for adult GCA
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AbbVie's upadacitinib (Rinvoq)…
News
Rare disease treatments skipping UK patients largely due to costs, survey shows
Medigene and EpimAb to develop T cell engagers for solid tumours
Why pharma is still far from a treatment for galactosemia
FDA accepts Sobi’s Gamifant application for HLH/MAS treatment
Alltrna plans to tackle rare diseases using tRNA-based therapies
Zevra sells priority review voucher for $150m to support drug launches
New EU trial regulations could expedite approvals and address shortages
